France · Biotechnology Research startup
France · Eligo Bioscience
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Funding reportedLast round: Series B
What company datasets say Eligo Bioscience raised
Funding, as reported
Reported in all69.7Min the source's currency
Rounds9
Last roundSeries B
Last round dateDec 2023
Investors listed9
Founders and team
From Eligo Bioscience's own website: 1 founder, 17 on the team.
- Ambre BordasOperations & Administrative Coordinator
- Andreas BrodelChief Operating Officer
- Aurélie GrienenbergerChief Operating Officer
- Daria IvanovaOperations & Administrative Coordinator
- Mary SpellmanChief Medical Officer
- Tamsin LacourteChief of Staff
- Antoine DecrulleVP Research
- Aurélie MathieuHead of Process Development
- Jesus Fernandez-RodriguezVP Technology
- Julien DeroyerHead of CMC
- Benoit BarteauBoard Director
- Blanche KerorgantJunior Project Manager
- Bobby GasparChairman of the Board
- Iain WilcockBoard Director
- Laia Crespo-MartinBoard Director
- Nessan BerminghamBoard Director
- Patricia AmazanLab Manager
AdvisersProf. David BikardProf. Luciano MarraffiniProf. Timothy Lu
Biotechnology Research in France
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Eligo Bioscience in front of investors. Or tell us what we have wrong.